United Kingdom

Mitsubishi Tanabe Pharma Corp (4508.T)

4508.T on Tokyo Stock Exchange

15 Feb 2019
Change (% chg)

¥-37 (-2.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Masayuki Mitsuka

62 2015 Executive President, President, Representative Director

Hiromi Okatake

2017 Chief Compliance Officer, Executive Officer, Director of Legal Affairs & Intellectual Property

Takashi Kobayashi

61 2017 Senior Managing Executive Officer, Chief Director of CMC, Representative Director

Yoshiaki Ishizaki

62 2016 Managing Executive Officer, Chief Director of Sales, Director

Seiichi Murakami

60 2017 Managing Executive Officer, Chief Director of Drug Fostering & Evolution, Director